Holly Soares

Holly Soares serves as the Global Head of Neuroscience and Rare Disease Biomarkers, VP at Roche since 2024. Previously, Holly held roles such as Head of Translational Neuroscience at AbbVie and Head of Precision Medicine at Pfizer, where they led biomarker strategies and drove translational research impacting drug development. With over fifteen years of experience in the biopharmaceutical industry, Holly specializes in developing biomarker strategies for various neurological and psychiatric conditions. Holly's academic background includes a Bachelor of Science in Neuroscience from Oberlin College and is pursuing a Doctor of Philosophy in Biomedical Science, Neuroscience at The University of Connecticut Health Center.